AdvaCare is a GMP manufacturer of Meclofenoxate HCL Powder for Injection.
Meclofenoxate HCL Powder for Injection, also known as centrophenoxine, is a drug used to treat the symptoms of senile dementia and Alzheimer’s disease.
Meclofenoxate is also indicated for the following conditions: comma; skull and brain trauma; following a stroke; encephalopathy; mental disorders (in combination with psychotropic agents); mental and psychomotor retardation in children; brain intoxication; alcohol psychoses; neuritis and polyneuritis.
As with all pharmaceuticals, some unwanted effects can occur from the use of Meclofenoxate HCL Powder for Injection. Always consult a doctor or health care professional for medical advice before use.
Common side effects include insomnia, dizziness, restlessness, muscle tremor, depression, nausea, muscle tension, and headache; these side effects may be due to overdosage and may indicate the need for the dosage to be reduced.
For a comprehensive list of all possible effects, consult your doctor.
If any symptom persists or gets worse, or you notice any other symptom, then please call your doctor immediately.